HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donald M Bers Selected Research

zinterol

6/2008Arrhythmogenic effects of beta2-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Donald M Bers Research Topics

Disease

63Heart Failure
01/2022 - 01/2002
27Cardiac Arrhythmias (Arrythmia)
01/2022 - 01/2002
12Hypertrophy
10/2020 - 05/2003
12Cardiomegaly (Heart Hypertrophy)
01/2019 - 05/2003
9Heart Diseases (Heart Disease)
10/2021 - 01/2008
7Ventricular Tachycardia
03/2016 - 01/2007
5Ischemia
01/2021 - 02/2006
5Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
07/2015 - 05/2003
4Diabetic Cardiomyopathies
10/2021 - 02/2012
4Atrial Fibrillation
01/2021 - 01/2017
4Cardiac Sudden Death (Sudden Cardiac Arrest)
06/2015 - 08/2008
4Long QT Syndrome
03/2014 - 12/2007
4Infections
03/2009 - 12/2004
3Muscular Diseases (Myopathy)
01/2022 - 02/2006
3Polymorphic catecholergic ventricular tachycardia
10/2021 - 08/2008
3Hyperglycemia
01/2021 - 01/2020
3Reperfusion Injury
01/2020 - 02/2006
3Inflammation (Inflammations)
01/2017 - 01/2015
3Cardiomyopathies (Cardiomyopathy)
04/2015 - 10/2012
3Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
04/2015 - 05/2005
3Sudden Death
03/2015 - 11/2002
3Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic)
04/2013 - 05/2005
2Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 01/2019
2Type 2 Diabetes Mellitus (MODY)
10/2021 - 02/2012
2Diabetes Mellitus
01/2020 - 10/2013
2Prediabetic State (Prediabetes)
01/2020 - 02/2012
2Mitochondrial Diseases (Mitochondrial Disease)
01/2019 - 10/2012
2Myocardial Infarction
01/2017 - 01/2014
2Infarction (Infarctions)
01/2017 - 04/2007
2Fibrosis (Cirrhosis)
08/2015 - 05/2005
2Cardiotoxicity
09/2013 - 04/2013
2Brugada Syndrome
06/2012 - 12/2007
1Long Qt Syndrome 2
01/2020
1Stroke (Strokes)
01/2020
1Long Qt Syndrome 3
01/2020
1Hypoxia (Hypoxemia)
01/2020
1Neoplasms (Cancer)
01/2020
1Diabetic Angiopathies (Diabetic Angiopathy)
01/2020
1Short Qt Syndrome
01/2020
1Rupture
01/2020
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2019
1Polyps
01/2019
1Fatigue
11/2018

Drug/Important Bio-Agent (IBA)

31Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
12/2021 - 05/2003
21Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2022 - 02/2002
17CalciumIBA
01/2022 - 01/2002
14Calcium-Calmodulin-Dependent Protein KinasesIBA
12/2021 - 12/2005
12Proteins (Proteins, Gene)FDA Link
01/2020 - 05/2003
11Adrenergic Agents (Adrenergic Drugs)IBA
01/2019 - 12/2005
6Calmodulin (Calcium-Dependent Activator Protein)IBA
10/2021 - 01/2014
5Phosphotransferases (Kinase)IBA
10/2021 - 06/2005
5Protein Isoforms (Isoforms)IBA
01/2021 - 05/2003
5SodiumIBA
06/2015 - 11/2003
5Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2012 - 02/2006
4Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 03/2011
4phospholambanIBA
01/2019 - 02/2006
4Adrenergic Receptors (Adrenergic Receptor)IBA
03/2016 - 05/2012
4Pharmaceutical PreparationsIBA
04/2015 - 01/2008
3Islet Amyloid PolypeptideIBA
01/2020 - 02/2012
3Peptides (Polypeptides)IBA
01/2019 - 02/2006
3Ion Channels (Ion Channel)IBA
06/2015 - 06/2009
3Adenosine Triphosphatases (ATPase)IBA
01/2014 - 10/2003
3Endothelin-1 (Endothelin 1)IBA
09/2011 - 03/2006
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2021 - 01/2019
2Histone Deacetylases (Histone Deacetylase)IBA
01/2021 - 03/2008
2Mitochondrial Permeability Transition PoreIBA
01/2020 - 01/2019
2E 4031IBA
01/2020 - 04/2011
2Amyloid (Amyloid Fibrils)IBA
01/2020 - 02/2012
2Transcription Factors (Transcription Factor)IBA
01/2020 - 06/2010
2Adenosine Triphosphate (ATP)IBA
01/2019 - 03/2014
2LipopolysaccharidesIBA
01/2017 - 01/2015
2KN 93IBA
03/2016 - 02/2006
2RanolazineFDA Link
09/2013 - 04/2011
2CalcineurinIBA
01/2012 - 09/2010
2Caffeine (No Doz)FDA LinkGeneric
12/2010 - 09/2004
1RE1-silencing transcription factorIBA
01/2022
1empagliflozinIBA
01/2022
1Oxidoreductases (Dehydrogenase)IBA
10/2021
1PK 11195 (PK11195)IBA
01/2021
1Inositol (Myoinositol)IBA
01/2021
1JNK Mitogen-Activated Protein KinasesIBA
01/2021
1Serine (L-Serine)FDA Link
01/2021
1toxin II (Anemonia sulcata)IBA
01/2020
16- (4- (trifluoromethoxy)phenyl)- 3- (trifluoromethyl)(1,2,4)triazolo(4,3- a)pyridineIBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1AcetylglucosamineIBA
01/2020
1PolymersIBA
01/2019
1Ketone BodiesIBA
01/2019
1Cyclophilins (Cyclophilin)IBA
01/2019
1Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA
01/2019
1Hormones (Hormone)IBA
01/2019
1OligomycinsIBA
01/2019
1PolyphosphatesIBA
01/2019
1Adenosine Diphosphate (ADP)IBA
01/2019
1Fatty Acids (Saturated Fatty Acids)IBA
11/2018
1InterleukinsIBA
01/2017
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2017

Therapy/Procedure

6Therapeutics
10/2021 - 03/2015
1Ovariectomy (Oophorectomy)
01/2019
1Endurance Training
01/2019